Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results January 25, 2017 Relmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone January 24, 2017 Relmada Therapeutics to Provide an Update on the Development Plan for LevoCap ER January 5, 2017 Relmada Therapeutics to Present at Biotech Showcase 2017 November 29, 2016 Relmada Therapeutics to Present at LD Micro “Main Event” Investor Conference October 27, 2016 Relmada Therapeutics to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention October 19, 2016 Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms October 6, 2016 Relmada Therapeutics to Present at the 15th Annual BIO Investor Forum September 28, 2016 Relmada Therapeutics’ Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston September 22, 2016 Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference September 20, 2016 Relmada Therapeutics to Present at the 2016 Aegis Growth Conference «...161718192021...»
